Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

MSFT
'Godfather of AI' Geoffrey Hinton on Regrets Over Inventing AI: Calls for FDA-Like Rules Before Releasing Models, Says Public Pressure Like Climate Change Could Drive Action

'Godfather of AI' Geoffrey Hinton on Regrets Over Inventing AI: Calls for FDA-Like Rules Before Releasing Models, Says Public Pressure Like Climate Ch...

NVDA
Ray Dalio Says AI Bubble Is ‘Close’ to Bursting as Debt and Rising Rates Raise Red Flags

Ray Dalio Says AI Bubble Is ‘Close’ to Bursting as Debt and Rising Rates Raise Red Flags...

INTC
Intel CEO Lip-Bu Tan Says Company Will Keep Working on Terafab — Elon Musk Confirms TSMC May Only Sublease Part of the Fab, Not Own It

Intel CEO Lip-Bu Tan Says Company Will Keep Working on Terafab — Elon Musk Confirms TSMC May Only Sublease Part of the Fab, Not Own It...

EOG
Robinhood's Investment Chief Says She Prefers Owning Energy Stocks Over ETFs — Should These Stocks Be on Your Radar?

Robinhood's Investment Chief Says She Prefers Owning Energy Stocks Over ETFs — Should These Stocks Be on Your Radar?...

IBM
IBM Ready Partners With SAP Solutions To Help Customers Accelerate Cloud ERP Modernization, Unify Enterprise Data, And Establish An AI-Ready Digital Core

IBM Ready Partners With SAP Solutions To Help Customers Accelerate Cloud ERP Modernization, Unify Enterprise Data, And Establish An AI-Ready Digital C...

TRV
Cantor Fitzgerald Maintains Overweight on Travelers Companies, Raises Price Target to $378

Cantor Fitzgerald Maintains Overweight on Travelers Companies, Raises Price Target to $378...

EQT
EQT, UnitedHealth, Clearway Energy And More On CNBC’s ‘Final Trades’

EQT, UnitedHealth, Clearway Energy And More On CNBC’s ‘Final Trades’...

AAPL
Reported Oct. 6: 'Apple to Launch Doorbell, Lock, Thermostat Developed With LG' - Bloomberg

Reported Oct. 6: 'Apple to Launch Doorbell, Lock, Thermostat Developed With LG' - Bloomberg...

TEM
Tempus Announces Expanded Collaboration With Merck And Moderna For Potential Commercialization Of Cancer Vaccine Intismeran Autogene; Terms Not Disclosed

Tempus Announces Expanded Collaboration With Merck And Moderna For Potential Commercialization Of Cancer Vaccine Intismeran Autogene; Terms Not Disclo...

INTC
Jim Cramer Says Investors Are Overlooking Elon Musk’s $40 Billion ‘Pot of Gold’ For Nvidia — Intel Terafab Exit Rumors ‘Squashed,’ Dismisses ‘Weakness’ In Korea’s Kospi

Jim Cramer Says Investors Are Overlooking Elon Musk’s $40 Billion ‘Pot of Gold’ For Nvidia — Intel Terafab Exit Rumors ‘Squashed,’ Dismisses ‘Weakness...

CVX
Chevron Swaps Hess Midstream Stake for 50% Lower Bakken Costs — and a $200 Million Payment

Chevron Swaps Hess Midstream Stake for 50% Lower Bakken Costs — and a $200 Million Payment...

MU
Most Undervalued Chip Stocks In October 2026: Four Are Cheaper Than The S&P 500

Most Undervalued Chip Stocks In October 2026: Four Are Cheaper Than The S&P 500...

MSFT
Evercore ISI Group Maintains Outperform on Microsoft, Raises Price Target to $635

Evercore ISI Group Maintains Outperform on Microsoft, Raises Price Target to $635...

JNJ
Guggenheim Reiterates Buy on Johnson & Johnson, Maintains $287 Price Target

Guggenheim Reiterates Buy on Johnson & Johnson, Maintains $287 Price Target...

ZS
These Analysts Boost Their Forecasts On Zscaler

These Analysts Boost Their Forecasts On Zscaler...

MSFT
Nvidia Inside: Microsoft's New Laptop Runs AI Agents Without the Cloud

Nvidia Inside: Microsoft's New Laptop Runs AI Agents Without the Cloud...

MRK
Halozyme Says Dutch Court Upholds Its Patent, Bars Merck From Making And Selling Keytruda SC In Multiple European Markets

Halozyme Says Dutch Court Upholds Its Patent, Bars Merck From Making And Selling Keytruda SC In Multiple European Markets...

SPCX
Reported October 6, FCC Approves SpaceX NGSO MSS System For Direct-To-Device Services

Reported October 6, FCC Approves SpaceX NGSO MSS System For Direct-To-Device Services...

CSCO
Cisco Launches Agentic Partnership

Cisco Launches Agentic Partnership...

AMGN
Morgan Stanley Maintains Equal-Weight on Amgen, Lowers Price Target to $359

Morgan Stanley Maintains Equal-Weight on Amgen, Lowers Price Target to $359...